Diagnosis is primarily based on a combination of patient symptoms, travel history, and laboratory tests. RT-PCR (reverse transcription-polymerase chain reaction) testing is used to detect viral RNA in blood or other body fluids. Serological tests can also be used to identify Zika virus antibodies, although cross-reactivity with other flaviviruses may complicate interpretation.
